Healthtech Startups

PT Samator Indo Gas is an industrial gas manufacturer producing chemicals such as nitrogen, oxygen, and carbon dioxide for industrial applications. The company is the largest national industrial gas company and is publicly listed on the Indonesian Stock Exchange.

1 investor

samedi provides cloud-based e-health software for medical practices, MVZs, and hospitals to manage online appointment scheduling, resource planning, digital patient forms, automated patient communication, video consultations, and white-label patient portals. The software integrates with existing practice management systems (PVS/KIS) and is offered primarily in Germany.

1 investor

Samepage builds an AI-powered information management platform for Product Managers that automatically surfaces insights and alignment data from scattered feedback, roadmaps, and research. The platform serves product teams at growing companies to eliminate information asymmetry and maintain alignment as organizations scale.

1 investor

SAMGI provides managed surgicalist programs for hospitals, with particular expertise in emergency surgical procedures, using standardized data-driven guidelines to integrate community surgeons and improve patient outcomes. Its programs aim to enhance surgical department performance, support ACS trauma accreditation, and optimize hospital efficiency and reimbursement.

1 investor

Revv provides AI-enabled software that diagnoses advanced driver assistance systems (ADAS) for automotive repair shops, aiming to increase shop revenue and vehicle safety.

1 investor

SampleFacts develops microsampling devices for simplified blood cell and plasma collection, targeting researchers, clinical study professionals, and healthcare providers. The company builds on university research to enable easier, faster, and more reliable blood sampling for research, clinical studies, and diagnostics.

1 investor

Sanavia discovers novel cancer-specific epitopes using proprietary immunization technology and AI to enable more effective antibody therapies for oncology. The company develops epitope discovery platforms and antibody drug candidates targeting multiple cancer types to expand treatment options for patients.

1 investor

Sandata provides an integrated platform that connects managed care organizations, homecare providers, and state agencies to improve communication and operational efficiency in home healthcare delivery. The company serves homecare agencies, intellectual/developmental disability service providers, managed care organizations, and state Medicaid programs.

1 investor

Sanii provides in-home elderly care services in Brazil, offering personalized care plans that cover mobility assistance, meal preparation, medication reminders, nursing care, and support for Alzheimer's and dementia. It serves families, caregivers, and elderly people seeking home-based gerontological care.

1 investor

SaniSure develops Mixed4Sure, a single-use mixing platform for small-volume biopharmaceutical processing that handles volumes from 50 mL to 20 L with reduced shear forces and lower capital costs than traditional stainless-steel systems.

1 investor

1 investor

Sanmirna Therapeutics develops microRNA-targeted therapeutics for cancer treatment, with its lead candidate Miristen™ currently in Phase I clinical trials for acute myeloid leukemia. The company leverages microRNA discovery to create novel oncology treatments.

1 investor

Sano provides physiotherapy services to private individuals, case handlers, employers, and NHS clients in the UK. The company delivers client-centered care with reported high satisfaction rates.

1 investor

Sanolla develops AI-powered digital stethoscopes and wearable devices that analyze full-spectrum body sounds including infrasound for diagnostic and home monitoring applications. The company serves healthcare professionals and chronic disease patients in primary care, cardiology, and pulmonology with real-time diagnostic insights and early detection capabilities.

1 investor

Back in Action UK provides onsite occupational physiotherapy and workplace ergonomics services to corporate and public sector clients, focusing on rehabilitating employees with musculoskeletal issues and reducing work-related injuries and absence. Founded in 2001, it works with occupational health companies and physicians across the UK, delivering services directly at client sites.

1 investor

Sanos provides clinical trial management services for pharmaceutical sponsors across multiple therapeutic areas, offering end-to-end capabilities from protocol development through regulatory approval. The company operates as a strategic partner for drug development, managing patient recruitment, data integrity, and operational execution with fixed budgets and timelines.

1 investor

SANSHO Co., Ltd. is a Japanese drug-development company creating pharmaceuticals based on cyclic phosphatidic acid (cPA), including 2-carba-cyclic phosphatidic acid candidates in clinical trials for knee osteoarthritis and pulmonary fibrosis. The company conducts research and development to bring these medicines to clinical use.

1 investor

Santa Ana Bio is a biotech company developing engineered antibody therapeutics that target the immune pathways and cells driving autoimmune and inflammatory diseases. It is building a pipeline of first-in-class and best-in-class biologics for conditions such as inflammatory bowel disease and scleroderma-associated interstitial lung disease.

1 investor

Santé is an investment firm managing over $1 billion in capital across healthcare and technology. Through Santé Ventures it backs private biotech, medtech, and healthtech companies, while Santé Capital runs a systematic liquid hedge fund strategy using its MindRank data-science and machine-learning software.

1 investor

Santé Académie is a French online continuing-education platform for healthcare professionals, offering on-demand video courses, live online sessions, and expert-led training. As a Qualiopi- and ANDPC-certified training organization, its courses are eligible for state and sector funding (DPC, ANFH, OPCO Santé, FIF-PL, FAF-PM).

1 investor

Santechture builds revenue cycle management (RCM) technology that helps healthcare providers manage claims and get paid, with systems designed for GCC regulatory standards such as the Saudi Billing System (SBS) and NPHIES. Founded in 2010, it serves healthcare facilities across the Middle East.

1 investor

Santero is a Belgium-based biotech company developing antibacterial drugs, including an RSH inhibitor programme targeting Pseudomonas aeruginosa and multidrug-resistant pathogens. It runs drug discovery and preclinical development spanning computational chemistry, medicinal chemistry, and screening toward clinical development.

1 investor

Santevia manufactures a countertop water filtration system that filters contaminants and adds back essential minerals for consumer home use. The Glass Water System combines filtration and mineralization in a hand-crafted glass and bamboo design.

1 investor

Saol Therapeutics is a clinical-stage pharmaceutical company focused on developing therapies for CNS disorders, pain conditions, and orphan diseases. The company recently divested its commercial assets to concentrate on advancing its pipeline of late-stage clinical programs.

1 investor